Dog stem cell therapy available in Busan — 24H UN animal medical center Stem Cell Center in Daeyeon-dong Guide
Author: Yeo Jae-seung, Chief Director (Chief Director of 24H UN animal medical center, Director of Companion Animal Cardiology and Nephrology Center, Chief of Internal Medicine at 24H UN animal medical center) This content was prepared in compliance with relevant laws including the Medical Service Act.
Can you get dog stem cell therapy in Busan?
The 24H UN animal medical center, located in Daeyeon-dong, Busan, independently operates a stem cell center as a specialized department and systematically provides dog stem cell therapy 365 days a year, 24 hours a day.
Stem cell therapy is a field of regenerative medicine that utilizes undifferentiated cells that migrate to damaged tissue areas and demonstrate functions such as inflammation reduction, angiogenesis, immune regulation, and cell regeneration. Veterinary indications for intractable diseases such as joints, spine, and kidneys are gradually being established, and clinical applications in practice are steadily increasing.
However, this treatment is not equally applicable to all dogs. Treatment decisions and methods are determined through accurate diagnosis and comprehensive assessment by a veterinarian. If you are curious whether stem cell therapy is appropriate for your pet, it is recommended to start with a consultation with a specialist veterinarian.
What is dog stem cell therapy, and what conditions is it used for?
Stem cells are undifferentiated cells that have not yet acquired specific functions and migrate to damaged tissue areas to reduce inflammation, promote blood vessel formation, and regulate immune responses. Thanks to these characteristics, they are being used as a supplement for diseases where conventional drug therapy has limited effectiveness.
According to clinical analysis data from DailyVet, in domestic veterinary practice, stem cell therapy applications are most common for intervertebral disc disease (IVDD), medial patellar luxation, mitral valve insufficiency (MVD), chronic kidney disease (CKD), and pancreatitis, in that order. DailyMedi reporting also introduces joint and spine disease as the primary application fields for stem cell therapy.
Additionally, according to MedicalToday reporting, the clinical effectiveness of mesenchymal stem cell (MSC) intra-articular injection therapy is gradually being confirmed through veterinary research.
The table below summarizes the characteristics of major applicable diseases by category.
| Disease Classification | Representative Disease | Characteristics |
|---|---|---|
| Bone and muscle system disease | Intervertebral disc disease, medial patellar luxation | Response tends to appear relatively quickly in many cases |
| Heart disease | Mitral valve insufficiency (MVD) | To be reviewed with concurrent internal medicine treatment |
| Kidney disease | Chronic kidney disease (CKD) | May require relatively more treatment sessions |
| Gastrointestinal disease | Pancreatitis | Treatment applicability determined after condition stabilization |
| Immune disease | Immune-mediated disease | Treatment plan adjusted according to individual response |
Bone and muscle system diseases tend to show relatively rapid treatment response, while chronic degenerative diseases may require multiple treatment sessions, with response differences between individuals. The number and interval of treatments must be discussed sufficiently with your attending veterinarian before deciding.
Why 24H UN animal medical center Stem Cell Center is chosen
The 24H UN animal medical center Stem Cell Center provides customized pet care based on an inter-departmental collaboration system among specialist centers, managing complex diseases including internal medicine, cardiology, and nephrology together.
Stem cell therapy must be linked with underlying disease management rather than being a standalone treatment to be effective. From this perspective, the structure of multiple departments collaborating within a single center becomes a practical advantage.
According to DailyVet materials, a system where veterinarians directly culture and manage stem cells within an animal hospital is known to be favorable for shortening the steps to patient application and managing cell quality. Additionally, according to information from Konkuk University College of Veterinary Medicine Animal Hospital, autologous stem cell therapy typically proceeds in the sequence of general anesthesia followed by adipose tissue collection → cell culture (approximately 2 weeks) → intravenous administration.
Treatment applicability assessment is comprehensively reviewed from an internal medicine perspective by Chief Director Yeo Jae-seung, who completed a Ph.D. course in internal medicine at Chungnam National University College of Veterinary Medicine and has 10 years of clinical animal hospital experience. Rather than simply judging whether to administer stem cells, decisions are made by considering the current underlying disease state, overall physical condition, anesthesia feasibility, and treatment timing.
▪ Stem cell center independently operated as specialized department ▪ Collaborative linkage among 8 specialist centers including cardiology, nephrology, and internal medicine ▪ In-hospital cell culture management system ▪ Comprehensive treatment applicability assessment from internal medicine specialist perspective ▪ 365-day, 24-hour operation enabling emergency and nighttime response
Precautions for these individuals — matters to confirm before stem cell therapy and accessibility near Busan
Stem cell therapy may not be appropriate for all pets. If any of the following items apply to you, a thorough consultation with a veterinarian is essential before treatment.
▪ Cases where general anesthesia is impossible due to cardiac and pulmonary dysfunction (general anesthesia is required for autologous stem cell collection) ▪ Cases where acute bacterial or viral infection is currently in progress ▪ Cases where malignant tumors (cancer) are actively progressing ▪ Cases in end-stage organ failure where treatment response cannot be expected ▪ Cases where treatment is being rushed without stabilization of underlying disease
According to clinical data, blood tests and X-ray examinations are basic pre-treatment inclusions, and through these, current systemic condition is confirmed before treatment applicability is determined. Treatment cycle and frequency also vary depending on the type and severity of disease, so treatment plans are established based on individual assessment rather than standardized numbers.
Guardians searching for an animal hospital in Busan Nam-gu, animal hospital in Busan Yeonje-gu, or animal hospital in Busan Suyeong-gu can visit the 24H UN animal medical center in Daeyeon-dong on the same day. With a 365-day, 24-hour treatment system, you can access it at night or on weekends.
Start with a consultation for dog stem cell therapy in Busan now
If you're curious about the right direction for your pet, confirm it through consultation. The 24H UN animal medical center operates 365 days a year, 24 hours a day, providing customized pet care in Daeyeon-dong, Busan.
Stem cell therapy is a field where timing can affect treatment results. DailyMedi reporting also recommends beginning consultation when the effect of pain relievers gradually diminishes or changes in daily activities are detected. It may be a wise choice to first receive evaluation from a specialist veterinarian before symptoms progress further.
The decision on treatment is made by a veterinarian based on face-to-face consultation and test results. The purpose of the consultation stage is to understand your pet's current condition and confirm together whether stem cell therapy is an appropriate choice. We help you decide based on accurate information rather than premature judgment.
Consultation and initial assessment are possible even in nighttime or emergency situations, so please visit anytime you're concerned about your pet's condition.
You might be wondering about these things
Q1. What procedure does dog stem cell therapy involve? Autologous stem cell therapy proceeds in the sequence of general anesthesia followed by small amounts of adipose tissue collection, cell culture for approximately 2 weeks, and then intravenous administration. Allogeneic stem cell therapy can be administered directly without a collection process. After diagnosis, your attending veterinarian will guide you on the method appropriate for your pet.
Q2. How do autologous stem cells differ from allogeneic stem cells? Autologous stem cells are collected from your pet's own adipose tissue, so the possibility of immune rejection is low, but general anesthesia is required. Allogeneic stem cells utilize cells from donor animals, so they can be administered without anesthesia, but the appropriate method may differ depending on anesthesia feasibility and current health status. Please decide through consultation with a veterinarian.
Q3. How many sessions does it take before stem cell therapy shows results? The response timing differs depending on the type and severity of disease and individual condition. Bone and muscle system diseases may show relatively quick responses in some cases, but chronic degenerative diseases tend to show cumulative effects after multiple treatment sessions. It is difficult to determine treatment effectiveness, with significant individual differences, so treatment proceeds by monitoring progress together and adjusting plans.
Q4. Can stem cell therapy be received together with conventional drug therapy? In many cases, concurrent use with conventional drug therapy is possible, and proceeding with internal medicine management may actually be more favorable in terms of treatment effectiveness. The 24H UN animal medical center has a collaborative structure with various specialist centers including internal medicine, cardiology, and nephrology, enabling integrated management of pets with complex diseases. The exact possibility of concurrent treatment will be determined after consultation with your attending veterinarian.
This content was prepared in compliance with Article 32 of the Veterinarians Act, and specific matters should be consulted with a specialist.